US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist

0.006900
-0.000240-3.36%

15min DelayClose Jul 5 16:00 ET

214.67KMarket Cap0.01P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

(Q3)May 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-22.21%37.14K

278.00%81.65K

10.37%129.7K

-54.14%44.15K

-79.39%47.75K

-97.25%21.6K

-91.52%117.52K

-95.11%96.28K

-Cash and cash equivalents

-22.21%37.14K

278.00%81.65K

10.37%129.7K

-54.14%44.15K

-79.39%47.75K

-97.25%21.6K

-91.52%117.52K

-95.11%96.28K

Receivables

107.53%126.78K

-11.26%69.29K

17.13%94.61K

121.05%304.65K

-63.63%61.09K

-56.17%78.09K

-60.48%80.77K

-13.12%137.82K

-Other receivables

107.53%126.78K

-11.26%69.29K

17.13%94.61K

121.05%304.65K

-63.63%61.09K

-56.17%78.09K

-60.48%80.77K

-13.12%137.82K

Total current assets

50.61%163.92K

51.41%150.94K

13.12%224.31K

49.00%348.8K

-72.76%108.84K

-89.67%99.69K

-87.54%198.29K

-88.99%234.09K

Non current assets

Net PPE

--0

-39.92%236.47K

-37.10%274.73K

-36.36%313.22K

-34.71%353.22K

-33.47%393.61K

-32.06%436.79K

-29.07%492.17K

Investments and advances

----

--0

-79.39%116.22K

-79.17%176.09K

-75.59%239.48K

Total non current assets

--0

-53.62%236.47K

-55.17%274.73K

-57.19%313.22K

-52.15%353.22K

-55.88%509.82K

-58.82%612.88K

-56.32%731.65K

Total assets

-64.52%163.92K

-36.44%387.4K

-38.48%499.04K

-31.45%662.02K

-59.39%462.05K

-71.25%609.51K

-73.65%811.17K

-74.60%965.74K

Liabilities

Current liabilities

Payables

31.65%1.23M

42.37%1.17M

71.26%1.17M

128.06%1.24M

102.72%934.19K

93.48%820.56K

70.70%684.77K

30.34%543.23K

-accounts payable

-67.44%231.38K

-58.84%245.71K

-27.15%335.92K

217.67%1.02M

199.57%710.55K

197.79%596.91K

159.78%461.13K

65.47%319.59K

-Due to related parties current

346.46%998.48K

312.48%922.5K

274.18%836.83K

0.00%223.65K

Current debt and capital lease obligation

-16.03%1.29M

-25.47%1.31M

-23.60%1.34M

-16.97%1.33M

16.18%1.54M

65.00%1.76M

101.71%1.76M

52.39%1.61M

-Current debt

-16.03%1.29M

-25.47%1.31M

-23.60%1.34M

-16.97%1.33M

16.18%1.54M

65.00%1.76M

101.71%1.76M

52.39%1.61M

Current liabilities

1.98%2.52M

-3.93%2.48M

2.98%2.52M

19.70%2.57M

38.51%2.47M

73.09%2.58M

91.94%2.44M

46.14%2.15M

Non current liabilities

Total non current liabilities

--0

---1

--0

--2

--0

Total liabilities

1.98%2.52M

-3.93%2.48M

2.98%2.52M

19.70%2.57M

38.51%2.47M

73.09%2.58M

91.94%2.44M

46.14%2.15M

Shareholders'equity

Share capital

1,301.35%3.11K

2,183.06%2.83K

1,723.39%2.26K

1,192.74%1.6K

-98.49%222

-99.14%124

-99.13%124

-common stock

1,301.35%3.11K

2,183.06%2.83K

1,723.39%2.26K

1,192.74%1.6K

-98.49%222

-99.14%124

-99.13%124

-Preferred stock

--0

Retained earnings

-5.24%-24.76M

-16.89%-24.44M

-18.06%-24.26M

-18.02%-23.69M

-21.37%-23.53M

-15.20%-20.91M

-22.13%-20.55M

-24.31%-20.07M

Paid-in capital

21.81%22.4M

23.37%22.34M

23.34%22.24M

3.94%18.65M

3.21%18.39M

3.54%18.11M

5.68%18.03M

6.95%17.94M

Gains losses not affecting retained earnings

----

--0

86.82%-330.93K

87.04%-330.93K

-20.48%-2.63M

-35.11%-2.57M

-41.91%-2.51M

Other equity interest

----

0.00%3.46M

Total stockholders'equity

-17.25%-2.36M

-6.11%-2.09M

-23.58%-2.02M

-61.48%-1.91M

-210.41%-2.01M

-414.67%-1.97M

-190.39%-1.63M

-150.71%-1.18M

Total equity

-17.25%-2.36M

-6.11%-2.09M

-23.58%-2.02M

-61.48%-1.91M

-210.41%-2.01M

-414.67%-1.97M

-190.39%-1.63M

-150.71%-1.18M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022	(Q3)May 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-22.21%37.14K	278.00%81.65K	10.37%129.7K	10.37%129.7K	-54.14%44.15K	-79.39%47.75K	-97.25%21.6K	-91.52%117.52K	-91.52%117.52K	-95.11%96.28K
-Cash and cash equivalents	-22.21%37.14K	278.00%81.65K	10.37%129.7K	10.37%129.7K	-54.14%44.15K	-79.39%47.75K	-97.25%21.6K	-91.52%117.52K	-91.52%117.52K	-95.11%96.28K
Receivables	107.53%126.78K	-11.26%69.29K	17.13%94.61K	17.13%94.61K	121.05%304.65K	-63.63%61.09K	-56.17%78.09K	-60.48%80.77K	-60.48%80.77K	-13.12%137.82K
-Other receivables	107.53%126.78K	-11.26%69.29K	17.13%94.61K	17.13%94.61K	121.05%304.65K	-63.63%61.09K	-56.17%78.09K	-60.48%80.77K	-60.48%80.77K	-13.12%137.82K
Total current assets	50.61%163.92K	51.41%150.94K	13.12%224.31K	13.12%224.31K	49.00%348.8K	-72.76%108.84K	-89.67%99.69K	-87.54%198.29K	-87.54%198.29K	-88.99%234.09K
Non current assets
Net PPE	--0	-39.92%236.47K	-37.10%274.73K	-37.10%274.73K	-36.36%313.22K	-34.71%353.22K	-33.47%393.61K	-32.06%436.79K	-32.06%436.79K	-29.07%492.17K
Investments and advances	----	----	--0	--0	--0	--0	-79.39%116.22K	-79.17%176.09K	-79.17%176.09K	-75.59%239.48K
Total non current assets	--0	-53.62%236.47K	-55.17%274.73K	-55.17%274.73K	-57.19%313.22K	-52.15%353.22K	-55.88%509.82K	-58.82%612.88K	-58.82%612.88K	-56.32%731.65K
Total assets	-64.52%163.92K	-36.44%387.4K	-38.48%499.04K	-38.48%499.04K	-31.45%662.02K	-59.39%462.05K	-71.25%609.51K	-73.65%811.17K	-73.65%811.17K	-74.60%965.74K
Liabilities
Current liabilities
Payables	31.65%1.23M	42.37%1.17M	71.26%1.17M	71.26%1.17M	128.06%1.24M	102.72%934.19K	93.48%820.56K	70.70%684.77K	70.70%684.77K	30.34%543.23K
-accounts payable	-67.44%231.38K	-58.84%245.71K	-27.15%335.92K	-27.15%335.92K	217.67%1.02M	199.57%710.55K	197.79%596.91K	159.78%461.13K	159.78%461.13K	65.47%319.59K
-Due to related parties current	346.46%998.48K	312.48%922.5K	274.18%836.83K	274.18%836.83K	0.00%223.65K	0.00%223.65K	0.00%223.65K	0.00%223.65K	0.00%223.65K	0.00%223.65K
Current debt and capital lease obligation	-16.03%1.29M	-25.47%1.31M	-23.60%1.34M	-23.60%1.34M	-16.97%1.33M	16.18%1.54M	65.00%1.76M	101.71%1.76M	101.71%1.76M	52.39%1.61M
-Current debt	-16.03%1.29M	-25.47%1.31M	-23.60%1.34M	-23.60%1.34M	-16.97%1.33M	16.18%1.54M	65.00%1.76M	101.71%1.76M	101.71%1.76M	52.39%1.61M
Current liabilities	1.98%2.52M	-3.93%2.48M	2.98%2.52M	2.98%2.52M	19.70%2.57M	38.51%2.47M	73.09%2.58M	91.94%2.44M	91.94%2.44M	46.14%2.15M
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	---1	---1	--0	--2	--2	--0
Total liabilities	1.98%2.52M	-3.93%2.48M	2.98%2.52M	2.98%2.52M	19.70%2.57M	38.51%2.47M	73.09%2.58M	91.94%2.44M	91.94%2.44M	46.14%2.15M
Shareholders'equity
Share capital	1,301.35%3.11K	2,183.06%2.83K	1,723.39%2.26K	1,723.39%2.26K	1,192.74%1.6K	-98.49%222	-99.14%124	-99.14%124	-99.14%124	-99.13%124
-common stock	1,301.35%3.11K	2,183.06%2.83K	1,723.39%2.26K	1,723.39%2.26K	1,192.74%1.6K	-98.49%222	-99.14%124	-99.14%124	-99.14%124	-99.13%124
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-5.24%-24.76M	-16.89%-24.44M	-18.06%-24.26M	-18.06%-24.26M	-18.02%-23.69M	-21.37%-23.53M	-15.20%-20.91M	-22.13%-20.55M	-22.13%-20.55M	-24.31%-20.07M
Paid-in capital	21.81%22.4M	23.37%22.34M	23.34%22.24M	23.34%22.24M	3.94%18.65M	3.21%18.39M	3.54%18.11M	5.68%18.03M	5.68%18.03M	6.95%17.94M
Gains losses not affecting retained earnings	----	----	--0	--0	86.82%-330.93K	87.04%-330.93K	-20.48%-2.63M	-35.11%-2.57M	-35.11%-2.57M	-41.91%-2.51M
Other equity interest	----	----	----	----	0.00%3.46M	0.00%3.46M	0.00%3.46M	0.00%3.46M	0.00%3.46M	0.00%3.46M
Total stockholders'equity	-17.25%-2.36M	-6.11%-2.09M	-23.58%-2.02M	-23.58%-2.02M	-61.48%-1.91M	-210.41%-2.01M	-414.67%-1.97M	-190.39%-1.63M	-190.39%-1.63M	-150.71%-1.18M
Total equity	-17.25%-2.36M	-6.11%-2.09M	-23.58%-2.02M	-23.58%-2.02M	-61.48%-1.91M	-210.41%-2.01M	-414.67%-1.97M	-190.39%-1.63M	-190.39%-1.63M	-150.71%-1.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall